600 Couples to Take Part in Best HIV Treatment Strategy

About 600 Sero-discordant couples where one partner is HIV positive and the other is not will take part in a new research study to help decide the best HIV Treatment Strategy that will reduce the rate of infection in the population.

A study by the National Agency for Control of AIDS (NACA) is to help decide whether health workers choose to administer the anti-retroviral drug, Trvada- as a prevention or treatment for HIV/AIDS.

Multiple studies have established that anti-retroviral drugs could be used to reduce the rate of infection in a population in two different ways, known by the acronyms PrEP (Pre-Exposure Prophylis) and TasP (Treatment as Prevention).

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below